Wednesday's Top Upgrades (and Downgrades)

Analysts shift stance on CVS Caremark, BE Aerospace, and LogMeIn.

Jan 22, 2014 at 12:58PM

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature upgrades for CVS Caremark (NYSE:CVS) and B/E Aerospace (NASDAQ:BEAV). But it's not all good news. Before we get to those two, let's take a quick look at why one analyst is...

Logging out of LogMeIn
Remote computer access software maker LogMeIn (NASDAQ:LOGM) isn't due to report quarterly earnings till February 13, but one analyst isn't waiting around to get hit with any bad news. With the shares up some 50% over the past 12 months alone, banker Cowen & Co. is taking the money and running -- and downgrading LogMeIn stock to market perform.

Why? Well, there are a couple of reasons why Cowen might be worried about LogMeIn's future. The stock's not currently profitable -- that's a big one. It's also in the middle of a pretty big change in business model. LogMeIn recently warned users that it is discontinuing the freemium model of offering its "Ignition" remote access software to users free of charge, in hopes they'll like it so much that they will upgrade to more robust paid versions of the software. Henceforth, the company is offering only week-long trials of the software, after which they must either pay up or log out.

This is a move calculated to convert more free moochers to paying users of the software -- but it also has the potential to slow adoption of LogMeIn's products, and perhaps pinch revenue growth as well.

Speaking of which, that's another reason to worry about the stock: growth. Unprofitable today, LogMeIn is generating positive free cash flow of about $13.2 million annually. If you think the stock looks expensive at 65 times free cash flow, and a 21% projected growth rate, you may not want to stick around and see what happens to the stock's price if LogMeIn's business model switcheroo has the effect of slowing that growth rate down even further.

Does CVS spell B-U-Y?
Turning now to happier news, shareholders of mega pharmacy chain CVS Caremark are enjoying a nice boost to stock price today in the wake of an upgrade to strong buy at ISI Group. Here, too, growth is the story, with ISI predicting it will be "strong" going forward -- perhaps even stronger than the 15% growth rate projected by the majority of analysts.

It had better be a lot stronger than 15%, however, to justify the price tag the market is hanging on CVS stock today, though. Priced north of 19 times earnings today, CVS shares may not look all that expensive for a growth rate around 15%. But looks can be deceiving.

The problem at CVS, in a nutshell, is that the company's not generating quite as much cash as its GAAP "earnings" number suggests. Free cash flow for the past 12 months amounted to only about $3.9 billion, or just 88% of reported earnings. Factor CVS's $8.6 billion net debt load into the picture, and this company is selling for an enterprise value of roughly 23.5 times free cash flow.

Even if you argue that a small premium is justified on the stock of an oligopolist like CVS, which controls about 23% of the U.S. prescription pharmacy market, it's hard to see how paying an even greater premium would be justified. ISI may be optimistic about the stock's chances. I am not.

Time for B/E to fly?
And finally in today's story of "growth" stocks, we come to airplane interiors-maker B/E Aerospace, recipient of an upgrade to buy from analysts at Topeka Capital this morning. As describes the ratings change, Topeka is upgrading B/E on the theory that "as a leading manufacturer of aircraft passenger cabin interior products and a global distributor of aerospace fasteners and consumables, the Company is well positioned to benefit from cyclical and secular drivers in the commercial aerospace market."

To that extent, we agree. A supplier to both of the world's major airplane builders, Boeing and Airbus, B/E has benefited from a surge in airplane buying of late. As Topeka rightly points out, compound annual revenue growth at B/E has averaged about 20% over the past seven years, with operating profits growing even faster at 30%. And yet, at a P/E ratio flying north of 25, the company's success appears to be fully baked into B/E's stock price already.

Going forward, analysts are extrapolating B/E's past success far into the future, pegging the stock for 19% annualized earnings growth over the next five years. On its face, paying 25 times earnings for a dividend-less stock growing at 19% seems a bit optimistic (especially given that key customers like Boeing, on which B/E's growth depends, are only expected to grow at 11.5%). But the situation may be even worse than that. Over the past year, B/E generated only about $0.67 in real cash profits for every $1 it reported "earning" under GAAP. At today's prices, the shares now sell for 38 times annual free cash flow -- pricey even if we take 19% future growth as a given.

To me, this looks like a case of "great company, overpriced stock," plain and simple. Topeka may be right about the stock continuing to surge in 2014, as it did in 2013 -- but I wouldn't bet on it.

Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers